Cardiex notoriously fail to keep investor sentiment high, even if things are going well, they just get things done and you get an update in the quarterly.
They've got at least 1500 Pulses committed to Pharma group in January, not huge $ but a nice starting point.
Legacy products generated significant revenues and were used by top tier health care companies, deemed the gold standard.
Milestones such as OTC submission / other geographies are behind schedule - look forward to the update.
The quarterly will be interesting, concerned cash position won't be encouraging. At this point I hope CDX Pulse has garnered the attention of professional/strategic investors, should we need funds, and they build from the launch.
Still has the hero or zero feel about it, currently $24mil MC with that multi billion $ potential. Unimpressed with where the share price is, but I think it's a speculative buy. Need the Pulse to get further approvals and gain some traction.
Add to My Watchlist
What is My Watchlist?
